Literature DB >> 7710719

Regulation of autoimmune response.

W M Ridgway1, H L Weiner, C G Fathman.   

Abstract

Recent work on such apparently disparate fields as T-cell receptor peptide-induced regulation, superantigens, antigen-induced tolerance, models of peripheral tolerance, apoptosis, and T-cell receptor antagonists demonstrates a similarity in immune response from a regulatory perspective. In many systems, a 'tolerance' pathway is observed, characterized broadly as an initial disturbance in the immune system, with a resulting predominance of effector cells, followed by a homeostatic response (often requiring CD8+ cells) which leads the effector population into T-cell receptor downregulation, T-cell inactivation, anergy and, often, eventual apoptotic death. In the regulated immune response, mixed populations of anergized and apoptosing T cells can be found. In some cases, anergy appears to lead to death while, in other instances, cells revert to a functional state. This review focuses on recent papers examining each of these topics in an attempt to obtain a preliminary integrated picture of immune regulation in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7710719     DOI: 10.1016/0952-7915(94)90018-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  6 in total

1.  Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.

Authors:  T C Martins; A P Aguas
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  Attenuation of macrophage apoptosis by the cAMP-signaling system.

Authors:  A von Knethen; B Brüne
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 3.  Virus-induced immunopathology.

Authors:  B T Rouse
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

Review 4.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

Authors:  I André; A Gonzalez; B Wang; J Katz; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

5.  Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

Authors:  M P Vierboom; H W Nijman; R Offringa; E I van der Voort; T van Hall; L van den Broek; G J Fleuren; P Kenemans; W M Kast; C J Melief
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

6.  Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy.

Authors:  S Kishi; S Saijyo; M Arai; S Karasawa; S Ueda; M Kannagi; Y Iwakura; M Fujii; S Yonehara
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.